Catalyst Wire Dossier Catalyst Wire Dossier

Oxycodone/naloxone prolonged release

oxycodone/naloxone · Napp Pharmaceuticals Limited
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Oxycodone/naloxone prolonged release, covering 2011-11-02 to 2018-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms [Phase 3]

See pricing